Lite Strategy, Inc. — Director's Dealing 2017

Jul 10, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2017-07-06

Reporting Person: GOLD DANIEL P PHD (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-06	Option to purchase shares of common stock	$2.83	A	380000	Acquired	2027-07-06	Common Stock par value $0.00000002 (380000)	Direct

Footnotes

F1: One-quarter of the options will vest on July 6, 2018; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months.

F2: The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012.